Urology Laser Market

Executive Summary

Urology Laser Market was valued at US $2.79 billion in 2021 and is projected to grow at 14.30% CAGR over the forecast period to reach US $6.22 billion by 2027. Urology Laser Market represented US $0.65 billion opportunity over 2019-2021 and estimated to create US $3.43 billion opportunity in 2027 over 2021.

Urology Laser from Consainsights analyses the Urology Laser Market in the Life Sciences industry over the forecast period to 2027.

Urology Laser research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Urology Laser segmentation includes Laser Type, Application and Geography.

Based on the Laser Type, the Urology Laser analysis covers Holmium Laser System, Diode Laser Systems, Thulium Laser System, Other Laser Types.

In Laser Type segment, Holmium Laser System segment has highest cagr growth of 12.62%.

Based on the Application, the Urology Laser analysis covers Benign Prostatic Hyperplasia, Urolithiasis, Non-Muscle-Invasive Bladder Cancer, Other Applications.

In Application segment, Benign Prostatic Hyperplasia segment has highest cagr growth of 12.62%.

Based on the region, the Urology Laser analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Allengers, Biolitec AG, Boston Scientific Corporation, Cook Group, El.En. Group, Lumenis, Medtronic, Olympus Corporation, OmniGuide Holdings, Inc, Richard Wolf GmbH, Surgical Lasers Inc. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Laser Type

Introduction

In 2021, Holmium Laser System segment has the highest revenue of US $1.22 billion and is expected to grow at CAGR of 12.62% by 2027 Holmium Laser System segment has highest cagr growth of 12.62%.

Holmium Laser System

Holmium Laser System segment was valued at US $0.93 billion in 2019 and is projected to grow at 12.62% CAGR over the forecast period to reach US $2.72 billion by 2027. Holmium Laser System segment represented US $0.29 billion opportunity over 2019-2021 and estimated to create US $1.50 billion opportunity in 2027 over 2021.

Diode Laser Systems

Diode Laser Systems segment was valued at US $0.61 billion in 2019 and is projected to grow at 12.62% CAGR over the forecast period to reach US $1.77 billion by 2027. Diode Laser Systems segment represented US $0.19 billion opportunity over 2019-2021 and estimated to create US $0.98 billion opportunity in 2027 over 2021.

Thulium Laser System

Thulium Laser System segment was valued at US $0.48 billion in 2019 and is projected to grow at 12.62% CAGR over the forecast period to reach US $1.41 billion by 2027. Thulium Laser System segment represented US $0.15 billion opportunity over 2019-2021 and estimated to create US $0.78 billion opportunity in 2027 over 2021.

Other Laser Types

Other Laser Types segment was valued at US $0.11 billion in 2019 and is projected to grow at 12.62% CAGR over the forecast period to reach US $0.31 billion by 2027. Other Laser Types segment represented US $0.03 billion opportunity over 2019-2021 and estimated to create US $0.17 billion opportunity in 2027 over 2021.

Application

Introduction

In 2021, Benign Prostatic Hyperplasia segment has the highest revenue of US $1.43 billion and is expected to grow at CAGR of 12.62% by 2027 Benign Prostatic Hyperplasia segment has highest cagr growth of 12.62%.

Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia segment was valued at US $1.09 billion in 2019 and is projected to grow at 12.62% CAGR over the forecast period to reach US $3.18 billion by 2027. Benign Prostatic Hyperplasia segment represented US $0.33 billion opportunity over 2019-2021 and estimated to create US $1.75 billion opportunity in 2027 over 2021.

Urolithiasis

Urolithiasis segment was valued at US $0.59 billion in 2019 and is projected to grow at 12.62% CAGR over the forecast period to reach US $1.73 billion by 2027. Urolithiasis segment represented US $0.18 billion opportunity over 2019-2021 and estimated to create US $0.95 billion opportunity in 2027 over 2021.

Non-Muscle-Invasive Bladder Cancer

Non-Muscle-Invasive Bladder Cancer segment was valued at US $0.40 billion in 2019 and is projected to grow at 12.62% CAGR over the forecast period to reach US $1.16 billion by 2027. Non-Muscle-Invasive Bladder Cancer segment represented US $0.12 billion opportunity over 2019-2021 and estimated to create US $0.64 billion opportunity in 2027 over 2021.

Other Applications

Other Applications segment was valued at US $0.05 billion in 2019 and is projected to grow at 12.62% CAGR over the forecast period to reach US $0.15 billion by 2027. Other Applications segment represented US $0.02 billion opportunity over 2019-2021 and estimated to create US $0.08 billion opportunity in 2027 over 2021.